Trials / Unknown
UnknownNCT01011621
Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis
Comparative Evaluation of the Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in the Treatment of Pediatric and Adult Dermatosis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- Sponsor
- Mantecorp Industria Quimica e Farmaceutica Ltd. · Industry
- Sex
- All
- Age
- 12 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Topical corticosteroids are largely used in dermatology. The major problem related to their use is that the same mechanisms underlying their therapeutic effects (antiinflammatory and antiproliferative) may lead to adverse events. Conditions sensitive to corticosteroids require formulations with mild to moderate potency while high-potency corticosteroids era required in less responsive conditions. The aim of the present study is to compare the safety and efficacy of prednisolone acetate 0.5% cream (mild-potency non-fluoridated corticosteroid) versus betamethasone valerate 0.1% cream (high-potency fluoridated corticosteroid) in the treatment of mild to moderate cortisosensitive dermatosis (atopic dermatitis, contact dermatitis, seborrheic dermatitis and psoriasis). The study hypothesis is that 0.5% prednisolone cream will be as effective as 0.1% betamethasone cream and will be an alternative option to treat corticosensitive dermatosis in body areas where the use of fluoridated corticosteroids is contraindicated, such as the face.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.5% prednisolone acetate cream | Small amount applied over the lesion twice a day for 14 days. |
| DRUG | 0.1% betamethasone valerate cream | Small amount applied over the lesion twice a day for 14 days. |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2012-02-01
- First posted
- 2009-11-11
- Last updated
- 2009-11-11
Source: ClinicalTrials.gov record NCT01011621. Inclusion in this directory is not an endorsement.